📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups. (2019)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41375-018-0351-2

PubMed Identifier: 30635634

Publication URI: http://europepmc.org/abstract/MED/30635634

Type: Journal Article/Review

Volume: 33

Parent Publication: Leukemia

Issue: 7

ISSN: 0887-6924